RI
RXST icon

RTW Investments’s RxSight RXST Stock Holding History

RTW Investments’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-150,000
Closed -$2.11M – 99
2022
Q2 		$2.11M Hold
150,000
– – 0.05% 95
2022
Q1 		$1.86M Hold
150,000
– – 0.04% 90
2021
Q4 		$1.69M Hold
150,000
– – 0.02% 113
2021
Q3 		$1.9M Buy
+150,000
New +$2.06M 0.03% 110

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return

RTW Investments's RXST Position: Q3 2022 in Review

RTW Investments sold out of RxSight (RXST) in Q3 2022, closing a stake of 150,000 shares — an estimated $2.11M sold.

RTW Investments first reported a position in RXST in Q3 2021 and held it in 4 quarters. The position peaked at $2.11M in Q2 2022. 53 funds tracked by Wall St. Rank hold RXST as of Q3 2022.

  • RTW Investments reported no remaining RxSight position as of Q3 2022 after selling out during the quarter.
  • RTW Investments sold 150,000 RxSight shares in Q3 2022, an estimated $2.11M.
  • RTW Investments first reported a position in RxSight in Q3 2021 and held it in 4 quarters.
  • RTW Investments's RxSight position peaked at $2.11M in Q2 2022.
  • 53 funds tracked by Wall St. Rank held RxSight as of Q3 2022.

Based on RTW Investments's 13F filing for Q3 2022, filed 14 Nov 2022.